At Week 24, the study doctor assessed patients’ asthma control. Patients taking low-
dose triple therapy could switch to high-dose triple therapy if their asthma was not well
controlled. The doctors and patients knew which treatment they received. This is called
an open-label study.
Which patients were included in this study?
Studies have a list of requirements for patients who can enrol (inclusion criteria) and
those who can’t (exclusion criteria). For this study, the main inclusion and exclusion
criteria are listed below.
Japanese men and women were included in the study if they:
• Were at least 18 years old.
• Had been diagnosed with asthma at least one year before starting the
study.
• Were taking asthma treatment with medium to high-dose of ICS and
LABA with or without LAMA for at least four weeks before starting the
study.
• Had controlled or not well-controlled asthma as scored using an asthma
scoring scale.
Men and women were excluded from the study if they:
• Had worsened asthma symptoms that required a change in their regular
asthma medicine within six weeks before starting the study.
• Had chronic obstructive pulmonary disease or any other lung disease.
• Were current smokers or former smokers with a history of smoking at
least 20 cigarettes daily for 10 years.
• Had pneumonia within six weeks before starting the study.
• Had a risk of developing pneumonia during the study.
• Had unstable liver or heart disease or any other disease that the study